tiprankstipranks
Trending News
More News >
Avalo Therapeutics, Inc. (AVTX)
NASDAQ:AVTX

Avalo Therapeutics (AVTX) Revenue

Compare
1,031 Followers

Avalo Therapeutics Revenue

Avalo Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 192.00K, Increased -56.46%. In the fiscal year ending Dec 31, 2024, Avalo Therapeutics had annual revenue of 441.00K with -77.08% growth.
Revenue (ttm)
192.00K
Revenue Growth
-76.59%
P/S Ratio
777.58
Revenue/Employee
$19,174
Employees
23
Market Cap
$342.91M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
441.00K-1.48M+22.92%
Dec 31, 2023
1.92M-16.13M+10.66%
Dec 31, 2022
18.05M12.65M+334.40%
Dec 31, 2021
5.40M-1.30M+80.58%
Dec 31, 2020
6.70M-51.35K+99.24%
Dec 31, 2019
6.75M-11.58M+36.83%
Dec 31, 2018
18.33M-9.49M+65.89%
Dec 31, 2017
27.81M26.66M+2,412.24%
Dec 31, 2016
1.15M